Last reviewed · How we verify

NCT05763108

Clinical Significance and Coexistence of Polymorphisms of Individual Collagen-coding Genes

Completed Last updated 4 April 2024
What this trial tests

trial testing genetic test in Ligament; Laxity in 250 participants. Completed in 20 December 2023.

Timeline
1 April 2022
Primary endpoint
1 April 2023
20 December 2023

Quick facts

Lead sponsorPolish Mother Memorial Hospital Research Institute
StatusCompleted
Study typeOBSERVATIONAL
Enrollment250
Start date1 April 2022
Primary completion1 April 2023
Estimated completion20 December 2023
Sites2 locations across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Polish Mother Memorial Hospital Research Institute

Who can join

Adults 7 to 17, any sex, with Ligament; Laxity or Recurrent Patellar Dislocation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess correlation between recurrent patella dislocation and genetic polymorphism rs1800012 of the COL1A1 Gene and rs12722 of the COL5A1 Gene.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of genetic test

Trials testing the same drug.

Other Polish Mother Memorial Hospital Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05763108.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing